After the oral administration of tritiated 3β,21-dihydroxypregn-5-en-20-one (21-hydroxypregnenolone) to a normal subject, 40% of the radioactivity was excreted during the first 24 hr. The disulphate fraction which contained mainly 21-hydroxypregnenolone 3,21-disulphate, accounted for 62 % of the total radioactivity. The monosulphate fraction accounted for 6·8% of the total radioactivity. In the glucosiduronic acid fraction (8·7%) 21-hydroxypregnenolone, tetrahydrodeoxycorticosterone and allotetrahydrodeoxycorticosterone were detected.
After the simultaneous oral and intravenous administration of inert and tritiated 3β,17α,21-trihydroxypregn-5-en-20-one (17α,21-dihydroxypregnenolone) only 25·7% of the radioactivity was excreted in the first 24 hr. The monosulphate fraction, accounting for 64% of the total radioactivity, contained 3β,17α,20ξ,21-tetrahydroxypregn-5-en-20-one, dehydroepiandrosterone and 17α,21-dihydroxypregnenolone. In the glucosiduronic acid fraction (15%), 17β,21-dihydroxypregnenolone, tetrahydro-11-deoxycortisol, allotetrahydro-11-deoxycortisol, aetiocholanolone and androsterone were detected.
Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
| Sept 2018 onwards | Past Year | Past 30 Days | |
|---|---|---|---|
| Full Text Views | 1 | 0 | 0 |
| PDF Downloads | 2 | 0 | 0 |
Online ISSN: 1479-6805
Print ISSN: 0022-0795
Strengthening biomedical communities
to advance science and health
CONTACT US
Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK
Bioscientifica Ltd | Registered in England no 3190519
